Figure 2
From: Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT
Baseline PET variables by lesional response to 2 cycles of [177Lu]Lu-PSMA-617 RLT: (A) SUVmax on [68Ga]Ga-PSMA-11 PET/CT, (B) SUVmax on [18F]FDG PET/CT, and (C) FPQ, [18F]FDG SUVmax/[68Ga]Ga-PSMA-11 SUVmax quotient.
